Rolf Marschalek

31PUBLICATIONS
166CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursNeonatologyMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 22, 2026
Patient-specific genomic measurable residual disease markers for monitoring acute myeloid leukaemia and myeloid malignancy.

|Oct 28, 2025
CRISPR/Cas9-mediated t(4;11) translocation in human hematopoietic stem/precursor cells demonstrates plasticity to differentiate into either the myeloid or lymphoid lineage.

T Benz, P Larghero, C Meyer

|Aug 05, 2024
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia.

Michela Bardini, Grazia Fazio, Lilia Corral Abascal

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Nov 24, 2023
Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study.

Marketa Zaliova, Jan Zuna, Lucie Winkowska

|Oct 30, 2023
The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.

Lisa Reisbeck, Benedikt Linder, Georg Tascher

Pageof 6

Frequent Collaborators

4 joint publications

Rosemary Sutton

3 joint publications

Thomas Burmeister

3 joint publications

Mariana Emerenciano

3 joint publications

Giovanni Cazzaniga